1) Sessink PJ, Anzion RB, Van den Broek PH, Bos RP, Detection of contamination with antineoplastic agents in a hospital pharmacy department, Pharm Weekbl Sci, 1992, 14, 16-22.
2) Sugiura S, Asano M, Kinoshita K, Tanimura M, Nabeshima T, Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide, J Oncol Pharm Pract, 2011, 17, 14-19.
3) ASHP guidelines on handling hazardous drugs, Am J Health Syst Pharm, 2006, 63, 1172-1192.